Suppr超能文献

C134W(402C>G)FOXL2 突变在卵巢雌雄同体性母细胞瘤中缺失:对一种不寻常肿瘤发生的深入了解。

The C134W (402 C>G) FOXL2 mutation is absent in ovarian gynandroblastoma: insights into the genesis of an unusual tumour.

机构信息

Department of Pathology, Ninewells Hospital and Medical School, Dundee, Scotland, UK.

出版信息

Histopathology. 2012 Apr;60(5):838-42. doi: 10.1111/j.1365-2559.2011.04148.x. Epub 2012 Feb 1.

Abstract

AIMS

Ovarian gynandroblastomas are rare tumours that, by definition, comprise a combination of components resembling both female, typically granulosa cell tumour (GCT), and male, typically Sertoli or Sertoli/Leydig cell tumour (ST/SLT), sex cord/stromal differentiation. The histogenesis of these tumours is unknown and, in view of the very strong association between the C134W (402 C>G) FOXL2 mutation and adult-type GCT, we analysed a series of gynandroblastomas for this mutation.

METHODS AND RESULTS

Both components of each lesion were isolated by laser capture microdissection and the C134W (402 C>G) FOXL2 mutation was analysed by polymerase chain reaction sequencing. No mutation was identified in either the GCT or ST/SLT component of six cases, three of which contained adult-type GCT.

CONCLUSIONS

This suggests that, despite their similar morphological appearances, the GCT-like component of gynandroblastoma has a different molecular basis from conventional adult-type GCT. This finding underscores a more general principle that morphological similarity does not necessarily indicate molecular identity.

摘要

目的

卵巢雌雄同体性生殖细胞瘤是一种罕见的肿瘤,根据定义,它由同时类似于女性(典型为颗粒细胞瘤[GCT])和男性(典型为支持细胞或支持细胞/间质细胞瘤[ST/SLT])性索/间质分化的成分组成。这些肿瘤的组织发生尚不清楚,鉴于 C134W(402 C>G)FOXL2 突变与成人型 GCT 之间存在很强的相关性,我们分析了一系列雌雄同体性生殖细胞瘤是否存在该突变。

方法和结果

通过激光捕获显微切割分离每个病变的两个成分,并通过聚合酶链反应测序分析 C134W(402 C>G)FOXL2 突变。在 6 例中,有 3 例包含成人型 GCT,均未在 GCT 或 ST/SLT 成分中发现突变。

结论

这表明,尽管外观相似,但雌雄同体性生殖细胞瘤的 GCT 样成分与传统的成人型 GCT 具有不同的分子基础。这一发现强调了一个更普遍的原则,即形态相似不一定表示分子同一性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验